Quality of life after late invasive therapy for occluded arteries
- PMID: 19228620
- PMCID: PMC2724193
- DOI: 10.1056/NEJMoa0805151
Quality of life after late invasive therapy for occluded arteries
Abstract
Background: The open-artery hypothesis postulates that late opening of an infarct-related artery after myocardial infarction will improve clinical outcomes. We evaluated the quality-of-life and economic outcomes associated with the use of this strategy.
Methods: We compared percutaneous coronary intervention (PCI) plus stenting with medical therapy alone in high-risk patients in stable condition who had a totally occluded infarct-related artery 3 to 28 days after myocardial infarction. In 951 patients (44% of those eligible), we assessed quality of life by means of a battery of tests that included two principal outcome measures, the Duke Activity Status Index (DASI) (which measures cardiac physical function on a scale from 0 to 58, with higher scores indicating better function) and the Medical Outcomes Study 36-Item Short-Form Mental Health Inventory 5 (which measures psychological well-being). Structured quality-of-life interviews were performed at baseline and at 4, 12, and 24 months. Costs of treatment were assessed for 458 of 469 patients in the United States (98%), and 2-year cost-effectiveness was estimated.
Results: At 4 months, the medical-therapy group, as compared with the PCI group, had a clinically marginal decrease of 3.4 points in the DASI score (P=0.007). At 1 and 2 years, the differences were smaller. No significant differences in psychological well-being were observed. For the 469 patients in the United States, cumulative 2-year costs were approximately $7,000 higher in the PCI group (P<0.001), and the quality-adjusted survival was marginally longer in the medical-therapy group.
Conclusions: PCI was associated with a marginal advantage in cardiac physical function at 4 months but not thereafter. At 2 years, medical therapy remained significantly less expensive than routine PCI and was associated with marginally longer quality-adjusted survival. (ClinicalTrials.gov number, NCT00004562.)
2009 Massachusetts Medical Society
Figures
Similar articles
-
Coronary intervention for persistent occlusion after myocardial infarction.N Engl J Med. 2006 Dec 7;355(23):2395-407. doi: 10.1056/NEJMoa066139. Epub 2006 Nov 14. N Engl J Med. 2006. PMID: 17105759 Free PMC article. Clinical Trial.
-
Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction.Circulation. 2011 Nov 22;124(21):2320-8. doi: 10.1161/CIRCULATIONAHA.111.041749. Epub 2011 Oct 24. Circulation. 2011. PMID: 22025606 Free PMC article. Clinical Trial.
-
Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.N Engl J Med. 2011 Mar 17;364(11):1016-26. doi: 10.1056/NEJMoa1001508. N Engl J Med. 2011. PMID: 21410370 Clinical Trial.
-
Late percutaneous coronary intervention for the totally occluded infarct-related artery: a meta-analysis of the effects on cardiac function and remodeling.Catheter Cardiovasc Interv. 2008 May 1;71(6):772-81. doi: 10.1002/ccd.21468. Catheter Cardiovasc Interv. 2008. PMID: 18415952 Review.
-
Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.Health Technol Assess. 2000;4(23):1-153. Health Technol Assess. 2000. PMID: 11074393 Review.
Cited by
-
The trial to assess chelation therapy 2 (TACT2): Rationale and design.Am Heart J. 2022 Oct;252:1-11. doi: 10.1016/j.ahj.2022.05.013. Epub 2022 May 19. Am Heart J. 2022. PMID: 35598636 Free PMC article. Clinical Trial.
-
Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA.Circulation. 2022 Apr 26;145(17):1294-1307. doi: 10.1161/CIRCULATIONAHA.121.057363. Epub 2022 Mar 9. Circulation. 2022. PMID: 35259918 Free PMC article. Clinical Trial.
-
Original Article--Value of Pathological Q Waves and Angiographic Collateral Grade in Patients Undergoing Coronary Chronic Total Occlusion Recanalization: Cardiac Magnetic Resonance Study.J Saudi Heart Assoc. 2021 Apr 15;33(1):41-50. doi: 10.37616/2212-5043.1239. eCollection 2021. J Saudi Heart Assoc. 2021. PMID: 33880327 Free PMC article.
-
Assessing quality-of-life outcomes in cardiovascular clinical research.Nat Rev Cardiol. 2016 May;13(5):286-308. doi: 10.1038/nrcardio.2016.10. Epub 2016 Feb 18. Nat Rev Cardiol. 2016. PMID: 26888169 Review.
-
Depression as a Clinical Determinant of Dependence and Low Quality of Life in Elderly Patients with Cardiovascular Disease.Arq Bras Cardiol. 2015 Jun;104(6):443-9. doi: 10.5935/abc.20150034. Epub 2015 Apr 14. Arq Bras Cardiol. 2015. PMID: 26131699 Free PMC article.
References
-
- Hochman JS, Lamas GA, Knatterud GL, Buller CE, Dzavik V, Mark DB, Reynolds HR, White HD. Design and methodology of the Occluded Artery Trial (OAT) Am Heart J. 2005;150:627–42. - PubMed
-
- Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, Forman S, Ruzyllo W, Maggioni AP, White H, Sadowski Z, Carvalho AC, Rankin JM, Renkin JP, Steg PG, Mascette AM, Sopko G, Pfisterer ME, Leor J, Fridrich V, Mark DB, Knatterud GL. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355:2395–407. - PMC - PubMed
-
- Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, Cobb FR, Pryor DB. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index) Am J Cardiol. 1989;64:651–4. - PubMed
-
- Hlatky MA, Rogers WJ, Johnstone I, Boothroyd D, Brooks MM, Pitt B, Reeder G, Ryan T, Smith H, Whitlow P, Wiens R, Mark DB. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1997;336:92–9. - PubMed
-
- Ware JE, Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual & Interpretation Guide. Boston: Nimrod Press; 1993.
Publication types
MeSH terms
Associated data
Grants and funding
- U01 HL062509-08/HL/NHLBI NIH HHS/United States
- U01-HL062509/HL/NHLBI NIH HHS/United States
- U01 HL062257/HL/NHLBI NIH HHS/United States
- U01 HL062509-01A1/HL/NHLBI NIH HHS/United States
- U01 HL062509-04/HL/NHLBI NIH HHS/United States
- U01 HL062257-01A1/HL/NHLBI NIH HHS/United States
- U01 HL062509-02/HL/NHLBI NIH HHS/United States
- U01 HL062509-03/HL/NHLBI NIH HHS/United States
- U01 HL062509-06A1/HL/NHLBI NIH HHS/United States
- U01 HL062509-07/HL/NHLBI NIH HHS/United States
- U01 HL062509-05S1/HL/NHLBI NIH HHS/United States
- R01 HL062257/HL/NHLBI NIH HHS/United States
- U01 HL062257-05/HL/NHLBI NIH HHS/United States
- U01 HL062509-05/HL/NHLBI NIH HHS/United States
- U01-HL062257/HL/NHLBI NIH HHS/United States
- U01 HL062509/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous